DR. JOEL N HIRSCHHORN, MD, PHD
Medical Practice at Longwood Ave, Boston, MA
License number
Massachusetts 205112
Category
Medical Practice
Type
Pediatric Endocrinology
Address
Address
2
300 Longwood Ave, Boston, MA 02115
14 Oakmont Rd, Newton, MA 02459
14 Oakmont Rd, Newton, MA 02459
Phone
(617) 355-2129
(617) 730-0244 (Fax)
(617) 244-0108
(617) 730-0244 (Fax)
(617) 244-0108
Personal information
See more information about JOEL N HIRSCHHORN at radaris.comName
Address
Phone
14 Oakmont Rd, Newton, MA 02459
Newton, MA
14 Oakdale Rd, Newton Center, MA 02459
14 Oakmont Rd, Newton Center, MA 02459
Organization information
See more information about JOEL N HIRSCHHORN at bizstanding.comChildren's Hospital Boston - Joel N Hirschhorn MD
300 Longwood Ave #FEGAN4, Boston, MA 02115
Categories:
Physicians & Surgeons
Phone:
(617) 355-7476 (Phone)
Professional information
See more information about JOEL N HIRSCHHORN at trustoria.com
Professor Of Genetics/Pediatrics. Director, Obesity Research Center. Human Genetics Research, Pediatric Endocrinologist.
Professor Of Genetics/Pediatrics. Director, Obesity Research Center. Human Genetics Research, Pediatric Endocrinologist.
Position:
Harvard Medical School Concordia Foundation Professor of Genetics and Pediatrics at Children's Hospital Boston
Location:
Greater Boston Area
Industry:
Hospital & Health Care
Work:
Children's Hospital Boston
since Sep 2001
-
Harvard Medical School Concordia Foundation Professor of Genetics and Pediatrics
Joel N Hirschhorn, Boston MA
Joel N Hirschhorn, Boston MA
Specialties:
Pediatric Endocrinologist
Address:
300 Longwood Ave, Boston, MA 02115
Education:
Doctor of Medicine
Board certifications:
American Board of Pediatrics Sub-certificate in Pediatric Endocrinology (Pediatrics)
Dr. Joel N Hirschhorn, Boston MA - MD (Doctor of Medicine)
Dr. Joel N Hirschhorn, Boston MA - MD (Doctor of Medicine)
Specialties:
Pediatric Endocrinology
Address:
CHILDRENS HOSPITAL BOSTON
300 Longwood Ave, Boston 02115
(617) 355-6000 (Phone)
IMMUNOLOGY DV
300 Longwood Ave, Boston 02115
(617) 919-2484 (Phone), (617) 730-0528 (Fax)
Childrens Hospital Ped Endcrnly
333 Longwood Ave SUITE 2, Boston 02115
(617) 355-7476 (Phone)
CHILDRENS HOSPITAL BOSTON
300 Longwood Ave, Boston 02115
(617) 355-6117 (Phone), (617) 738-7066 (Fax)
300 Longwood Ave, Boston 02115
(617) 355-6000 (Phone)
IMMUNOLOGY DV
300 Longwood Ave, Boston 02115
(617) 919-2484 (Phone), (617) 730-0528 (Fax)
Childrens Hospital Ped Endcrnly
333 Longwood Ave SUITE 2, Boston 02115
(617) 355-7476 (Phone)
CHILDRENS HOSPITAL BOSTON
300 Longwood Ave, Boston 02115
(617) 355-6117 (Phone), (617) 738-7066 (Fax)
Certifications:
Pediatric Endocrinology, 2009, Pediatrics, 2000
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
Harvard Med Sch
Graduated: 1993
Children'S Hospital Boston
Harvard Med Sch
Graduated: 1993
Children'S Hospital Boston
Joel Naom Hirschhorn, Boston MA
Joel Naom Hirschhorn, Boston MA
Specialties:
Pediatrics, Pediatric Endocrinology
Work:
Children's Hospital
300 Longwood Ave, Boston, MA 02115
300 Longwood Ave, Boston, MA 02115
Education:
Harvard University(1995)
Association Of Protein Kinase C Zeta Polymorphisms With Diabetes
Association Of Protein Kinase C Zeta Polymorphisms With Diabetes
US Patent:
6562574, May 13, 2003
Filed:
Apr 25, 2001
Appl. No.:
09/842307
Inventors:
David M. Altshuler - Brookline MA
Joel N. Hirschhorn - Newton MA
Eric S. Lander - Cambridge MA
Joel N. Hirschhorn - Newton MA
Eric S. Lander - Cambridge MA
Assignee:
Whitehead Institute for Biomedical Research - Cambridge MA
The General Hospital Corporation - Boston MA
The General Hospital Corporation - Boston MA
International Classification:
C12Q 168
US Classification:
435 6, 435 912, 536 231, 536 235, 536 2431, 536 2433
Abstract:
A central role for the gene encoding protein kinase C zeta in diabetes and perhaps in related disorders is disclosed. Use of single nucleotide polymorphisms in the protein kinase C zeta gene for diagnosis, prediction of clinical course and treatment response, development of new treatments and development of cell-culture based and animal models for research and treatment are disclosed.
Methods For Selecting Primers
Methods For Selecting Primers
US Patent:
6440675, Aug 27, 2002
Filed:
Sep 18, 2000
Appl. No.:
09/663902
Inventors:
Ellen Winchester - Cambridge MA
Joel N. Hirschhorn - Newton MA
Pamela Sklar - Brookline MA
Joel N. Hirschhorn - Newton MA
Pamela Sklar - Brookline MA
Assignee:
Whitehead Institute for Biomedical Research - Cambridge MA
International Classification:
C12Q 168
US Classification:
435 6, 435 912
Abstract:
Methods for selecting primers having a reduced incidence of undesirable interactions are disclosed. Methods of improving the accuracy of SBE-fluorescence polarization (SBE-FP) methods are also disclosed.
Generic Sbe-Fret Protocol
Generic Sbe-Fret Protocol
US Patent:
6642001, Nov 4, 2003
Filed:
Jul 13, 2000
Appl. No.:
09/615216
Inventors:
Stacey Bolk - West Roxbury MA
Joel N. Hirschhorn - Newton MA
James S. Ireland - Somerville MA
Eric S. Lander - Cambridge MA
Joel N. Hirschhorn - Newton MA
James S. Ireland - Somerville MA
Eric S. Lander - Cambridge MA
Assignee:
Whitehead Institute for Biomedical Research - Cambridge MA
International Classification:
C12Q 168
US Classification:
435 6, 435 912, 935 77, 935 78, 536 2532, 436501
Abstract:
The present invention is drawn to methods for detection, quantitation and analysis of nucleotides of interest in nucleic acid sequences of interest using single base extension and fluorescence resonance energy transfer and generic donor molecule-labeled detection probes.
Compositions And Methods For Obesity Screening Using Polymorphisms In Npy2R
Compositions And Methods For Obesity Screening Using Polymorphisms In Npy2R
US Patent:
2008010, May 1, 2008
Filed:
Sep 19, 2005
Appl. No.:
11/663052
Inventors:
Joel Hirschhorn - Newton Center MA, US
Catarina deHaseth Campbell - Brookline MA, US
Kristin Ardlie - Boston MA, US
Catarina deHaseth Campbell - Brookline MA, US
Kristin Ardlie - Boston MA, US
Assignee:
CHILDRENS MEDICAL CENTER CORPORATION - Boston MA
SERACARE LIFE SCIENCES, INC. - Oceanside CA
SERACARE LIFE SCIENCES, INC. - Oceanside CA
International Classification:
C12Q 1/68
US Classification:
435 6
Abstract:
Methods and constructs are provided that are predictive of a subject's susceptibility to developing a metabolic disorder, such as obesity. The disclosed naturally-occurring SNPs located upstream of the NPY2R gene can be used as targets for the design of diagnostic reagents and the development of therapeutic agents, as well as for disease association and linkage analysis. In particular, the SNPs of the present invention are useful for identifying an individual who is at an increased or decreased risk of developing metabolic disorders, such as obesity and diabetes, and for early detection of the disease, for providing clinically important information for the prevention and/or treatment of metabolic disorder, and for screening and selecting therapeutic agents. The SNPs disclosed herein are also useful for human identification applications. Methods, assays, kits, and reagents for detecting the presence of these polymorphisms and their encoded products are provided.
Association Of Protein Kinase C Zeta Polymorphisms With Diabetes
Association Of Protein Kinase C Zeta Polymorphisms With Diabetes
US Patent:
2003017, Sep 18, 2003
Filed:
May 13, 2003
Appl. No.:
10/436919
Inventors:
David Altshuler - Brookline MA, US
Joel Hirschhorn - Newton MA, US
Eric Lander - Cambridge MA, US
Joel Hirschhorn - Newton MA, US
Eric Lander - Cambridge MA, US
Assignee:
Whitehead Institute for Biomedical Research - Cambridge MA
International Classification:
C12Q001/68, G01N033/53, C07H021/04, C12P021/02, C12N005/06, C12N009/12, C12M001/34
US Classification:
435/006000, 435/007100, 435/069100, 435/194000, 435/320100, 435/325000, 435/287200, 536/023200
Abstract:
A central role for the gene encoding protein kinase C zeta in diabetes and perhaps in related disorders is disclosed. Use of single nucleotide polymorphisms in the protein kinase C zeta gene for diagnosis, prediction of clinical course and treatment response, development of new treatments and development of cell-culture based and animal models for research and treatment are disclosed.
Universal Arrays
Universal Arrays
US Patent:
2005007, Apr 7, 2005
Filed:
Dec 8, 2003
Appl. No.:
10/730771
Inventors:
Joel Hirschhorn - Newton MA, US
Xiaohua Huang - Mountain View CA, US
Paul Kaplan - Campbell CA, US
Eric Lander - Cambridge MA, US
David Lockhart - Del Mar CA, US
Thomas Ryder - Los Gatos CA, US
Pamela Sklar - Brookline MA, US
Xiaohua Huang - Mountain View CA, US
Paul Kaplan - Campbell CA, US
Eric Lander - Cambridge MA, US
David Lockhart - Del Mar CA, US
Thomas Ryder - Los Gatos CA, US
Pamela Sklar - Brookline MA, US
Assignee:
Whitehead Institute for Biomedical Research - Cambridge MA
The General Hospital Corporation - Boston MA
Affymetrix, Inc - Santa Clara CA
The General Hospital Corporation - Boston MA
Affymetrix, Inc - Santa Clara CA
International Classification:
C12Q001/68
US Classification:
435006000
Abstract:
An array of oligonucleotides on a solid substrate is disclosed, which can be used for multiple purposes. Methods and reagents are provided for performing genotyping to determine the identity or ratio of allelic forms of a gene in a sample. A single base extension primer is coupled to a sequence identity code. During the primer extension reaction a distinctive label is incorporated which identifies the allelic form present in the sample. This permits multiple simultaneous analyses to be performed easily and efficiently.